Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer

Background The correlation between tumor markers (TM) and TNM stage of non-small-cell lung cancer (NSCLC) has not been widely reported. Methods TM levels (CEA, CA125, CA15-3, CA19-9, CA72-4, CYFRA21-1, and SCC-Ag) in 424 cases of lung adenocarcinoma (LAC), 166 cases of lung squamous cell carcinoma (LSCC), and 103 cases of benign chest disease (BCD) were analyzed before treatment. Results By Kendall's tau-b correlation analysis, CEA, CA125, CA15-3, CA19-9, CA72-4, CYFRA21-1, and SCC-Ag were correlated with T stage of LAC (r = 0.235, p < 0.05; r = 0.298, p < 0.05; r = 0.254, p < 0.05; r = 0.063, p < 0.05; r = 0.080, p < 0.05; r = 0.268, p < 0.05; and r = 0.080, p < 0.05). CEA, CA125, CA15-3, CA19-9, CA72-4, and CYFRA21-1 were correlated with N stage of LAC (r = 0.356, p < 0.05; r = 0.415, p < 0.05; r = 0.340, p < 0.05; r = 0.117, p < 0.05; r = 0.175, p < 0.05; and r = 0.351, p < 0.05). CEA, CA125, CA15-3, CA19-9, CA72-4, and CYFRA21-1 were correlated with M stage of LAC (r = 0.365, p < 0.05; r = 0.353, p < 0.05; r = 0.293, p < 0.05; r = 0.135, p < 0.05; r = 0.169, p < 0.05; and r = 0.312, p < 0.05). CA125, CYFRA21-1, and SCC-Ag were correlated with T stage of LSCC (r = 0.202, p < 0.05; r = 0.233, p < 0.05; and r = 0.099, p < 0.05). CA125 and CYFRA21-1 were correlated with N stage of LSCC (r = 0.178, p < 0.05 and r = 0.284, p < 0.05). CA125, CA15-3, and CYFRA21-1 were correlated with M stage of LSCC (r = 0.214, p < 0.05; r = 0.152, p < 0.05; and r = 0.213, p < 0.05). Combining hazard ratio, AUC, sensitivity, specificity, NPV, and PPV, it was concluded that CEA and CYFRA21-1were the most related TM of LAC. SCC-Ag and CYFRA21-1 were the most related TM of LSCC. Conclusions CEA combined with CYFRA21-1 contributed to auxiliary diagnosis of LAC. CYFRA21-1 combined with SCC-Ag contributed to auxiliary diagnosis of LSCC. CEA, CA125, CA15-3, CA19-9, CA72-4, and CYFRA21-1 were correlated with primary tissue and metastasis of LAC. CA125 and CYFRA21-1 were correlated with primary tissue and metastasis of LSCC.

[1]  H. Satoh,et al.  A re-evaluation of squamous cell carcinoma antigen (SCC) as a serum marker for non-small cell lung cancer , 2008, Medical oncology.

[2]  N. Iacovidou,et al.  Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations , 2015, Scandinavian journal of clinical and laboratory investigation.

[3]  K. Friedrich,et al.  Inverse association of rab31 and mucin-1 (CA15-3) antigen levels in estrogen receptor-positive (ER+) breast cancer tissues with clinicopathological parameters and patients' prognosis. , 2017, American journal of cancer research.

[4]  A. Leon-Justel,et al.  CYFRA 21-1 as a tool for distant metastasis detection in lung cancer. , 2011, Clinical laboratory.

[5]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Inclusion of Broncho-Pulmonary Carcinoid Tumors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  A. Agustí,et al.  Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer. , 2016, American journal of respiratory and critical care medicine.

[7]  K. Feldmann,et al.  Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer , 2008, Clinical Cancer Research.

[8]  J. Balibrea,et al.  Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non‐small cell lung cancer , 1994, Cancer.

[9]  M. Fang,et al.  Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma , 2019, Cancer medicine.

[10]  J. Daurès,et al.  Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. , 1993, Cancer research.

[11]  Wanqing Chen,et al.  Estimates of cancer incidence and mortality in China, 2013 , 2017, Chinese journal of cancer.

[12]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  Y. Nakanishi,et al.  Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer. , 2013, Lung cancer.

[14]  S. Sato,et al.  Relationship between CT features and high preoperative serum carcinoembryonic antigen levels in early-stage lung adenocarcinoma. , 2014, Clinical radiology.

[15]  M. Tomita,et al.  Correlation between Serum Carcinoembryonic Antigen Level and Histologic Subtype in Resected Lung Adenocarcinoma. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[16]  R. González-Sarmiento,et al.  Clinical value of p53, c‐erbB‐2, CEA and CA125 regarding relapse, metastasis and death in resectable non‐small cell lung cancer , 2003, International journal of cancer.

[17]  C. Coca,et al.  Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer. , 2003, Anticancer research.

[18]  A. Scharl,et al.  Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix , 1989, Cancer.

[19]  Zélia Silva,et al.  Cytokeratin 19, carcinoembryonic antigen, and epithelial cell adhesion molecule detect lung cancer lymph node metastasis in endobronchial ultrasound-guided transbronchial aspiration samples. , 2013, Clinical lung cancer.

[20]  R. Molina,et al.  Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site , 2012, Tumor Biology.

[21]  R. Bast,et al.  Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. , 1983, American journal of clinical pathology.

[22]  Jie He,et al.  Annual report on status of cancer in China, 2011. , 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[23]  T. Oyama,et al.  Lung adenocarcinoma with clear cell features producing carbohydrate antigen 19-9 , 2015, Asian cardiovascular & thoracic annals.

[24]  H. Satoh,et al.  Squamous Cell Carcinoma Antigen in Lung Cancer and Nonmalignant Respiratory Diseases , 2008, Lung.

[25]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[26]  David F. Smith,et al.  Identification of Tn Antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodies. , 2019, Glycobiology.

[27]  San-Gang Wu,et al.  Development and validation of a novel diagnostic model for assessing lung cancer metastasis in a Chinese population based on multicenter real-world data , 2019, Cancer management and research.

[28]  Jie He,et al.  [Clinical analysis of 126 patients with primary small cell carcinoma of the esophagus]. , 2008, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[29]  Kirsten Simon,et al.  Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis , 2017, British Journal of Cancer.

[30]  S Niho,et al.  [Tumor markers in lung cancer]. , 2001, Gan to kagaku ryoho. Cancer & chemotherapy.

[31]  H. Ren,et al.  [Detecting MUC-1 mRNA for diagnosing peripheral blood micro-metastasis in non-small cell lung cancer patients]. , 2008, Ai zheng = Aizheng = Chinese journal of cancer.

[32]  Jae Jun Kim,et al.  The Significance of Serum Carcinoembryonic Antigen in Lung Adenocarcinoma , 2015, The Korean journal of thoracic and cardiovascular surgery.

[33]  T. Iwakiri,et al.  [A case of lung cancer producing CA19-9 and amylase]. , 1993, Nihon Kyobu Shikkan Gakkai zasshi.

[34]  Y. Hu,et al.  Expression and prognostic relevance of MUC1 in stage IB non-small cell lung cancer , 2010, Medical oncology.

[35]  Wanqing Chen,et al.  The incidence and mortality of major cancers in China, 2012 , 2013, Chinese journal of cancer.

[36]  W. Riesen,et al.  [CYFRA 21-1: initial experiences in bronchus carcinoma and other tumors]. , 1994, Schweizerische medizinische Wochenschrift.

[37]  Hongliang Sun,et al.  Assessment of Relationship Between CT Features and Serum Tumor Marker Index in Early-stage Lung Adenocarcinoma. , 2016, Academic radiology.